PDS Biotechnology (PDSB) Change in Cash (2014 - 2025)

PDS Biotechnology (PDSB) has 12 years of Change in Cash data on file, last reported at $513317.0 in Q4 2025.

• Quarterly Change in Cash rose 106.37% year-over-year to $513317.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$15.0 million (down 0.72% YoY) and the FY2025 annual result came in at -$15.0 million, down 0.72% from the prior year.
• Change in Cash climbed to $513317.0 in Q4 2025, from -$5.7 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $49.7 million in Q2 2021 to a low of -$8.9 million in Q2 2024.
• A 5-year average of -$106379.8 and a median of -$4.8 million in 2021 frame the typical range for Change in Cash.
• Annual changes were most pronounced in 2021 — Change in Cash surged 1311.51% — and 2024, when it sank 449.12%.
• Tracing PDSB's Change in Cash over 5 years: stood at -$4.5 million in 2021, then jumped by 148.38% to $2.2 million in 2022, then increased by 6.03% to $2.3 million in 2023, then slumped by 449.12% to -$8.1 million in 2024, then soared by 106.37% to $513317.0 in 2025.
• The last three Change in Cash figures came in at $513317.0 (Q4 2025), -$5.7 million (Q3 2025), and -$8.1 million (Q2 2025), per Business Quant data.